Eine Plattform für die Wissenschaft: Bauingenieurwesen, Architektur und Urbanistik
Eine Plattform für die Wissenschaft: Bauingenieurwesen, Architektur und Urbanistik
APP‐C31: An Intracellular Promoter of Both Metal‐Free and Metal‐Bound Amyloid‐β40 Aggregation and Toxicity in Alzheimer's Disease
https://orcid.org/0000-0003-0801-9331
https://orcid.org/0000-0003-1844-2301
https://orcid.org/0000-0002-8832-8187
https://orcid.org/0000-0003-3377-4996
AbstractIntracellular C‐terminal cleavage of the amyloid precursor protein (APP) is elevated in the brains of Alzheimer's disease (AD) patients and produces a peptide labeled APP‐C31 that is suspected to be involved in the pathology of AD. But details about the role of APP‐C31 in the development of the disease are not known. Here, this work reports that APP‐C31 directly interacts with the N‐terminal and self‐recognition regions of amyloid‐β40 (Aβ40) to form transient adducts, which facilitates the aggregation of both metal‐free and metal‐bound Aβ40 peptides and aggravates their toxicity. Specifically, APP‐C31 increases the perinuclear and intranuclear generation of large Aβ40 deposits and, consequently, damages the nucleus leading to apoptosis. The Aβ40‐induced degeneration of neurites and inflammation are also intensified by APP‐C31 in human neurons and murine brains. This study demonstrates a new function of APP‐C31 as an intracellular promoter of Aβ40 amyloidogenesis in both metal‐free and metal‐present environments, and may offer an interesting alternative target for developing treatments for AD that have not been considered thus far.
APP‐C31: An Intracellular Promoter of Both Metal‐Free and Metal‐Bound Amyloid‐β40 Aggregation and Toxicity in Alzheimer's Disease
https://orcid.org/0000-0003-0801-9331
https://orcid.org/0000-0003-1844-2301
https://orcid.org/0000-0002-8832-8187
https://orcid.org/0000-0003-3377-4996
AbstractIntracellular C‐terminal cleavage of the amyloid precursor protein (APP) is elevated in the brains of Alzheimer's disease (AD) patients and produces a peptide labeled APP‐C31 that is suspected to be involved in the pathology of AD. But details about the role of APP‐C31 in the development of the disease are not known. Here, this work reports that APP‐C31 directly interacts with the N‐terminal and self‐recognition regions of amyloid‐β40 (Aβ40) to form transient adducts, which facilitates the aggregation of both metal‐free and metal‐bound Aβ40 peptides and aggravates their toxicity. Specifically, APP‐C31 increases the perinuclear and intranuclear generation of large Aβ40 deposits and, consequently, damages the nucleus leading to apoptosis. The Aβ40‐induced degeneration of neurites and inflammation are also intensified by APP‐C31 in human neurons and murine brains. This study demonstrates a new function of APP‐C31 as an intracellular promoter of Aβ40 amyloidogenesis in both metal‐free and metal‐present environments, and may offer an interesting alternative target for developing treatments for AD that have not been considered thus far.
APP‐C31: An Intracellular Promoter of Both Metal‐Free and Metal‐Bound Amyloid‐β40 Aggregation and Toxicity in Alzheimer's Disease
https://orcid.org/0000-0003-0801-9331
https://orcid.org/0000-0003-1844-2301
https://orcid.org/0000-0002-8832-8187
https://orcid.org/0000-0003-3377-4996
AbstractIntracellular C‐terminal cleavage of the amyloid precursor protein (APP) is elevated in the brains of Alzheimer's disease (AD) patients and produces a peptide labeled APP‐C31 that is suspected to be involved in the pathology of AD. But details about the role of APP‐C31 in the development of the disease are not known. Here, this work reports that APP‐C31 directly interacts with the N‐terminal and self‐recognition regions of amyloid‐β40 (Aβ40) to form transient adducts, which facilitates the aggregation of both metal‐free and metal‐bound Aβ40 peptides and aggravates their toxicity. Specifically, APP‐C31 increases the perinuclear and intranuclear generation of large Aβ40 deposits and, consequently, damages the nucleus leading to apoptosis. The Aβ40‐induced degeneration of neurites and inflammation are also intensified by APP‐C31 in human neurons and murine brains. This study demonstrates a new function of APP‐C31 as an intracellular promoter of Aβ40 amyloidogenesis in both metal‐free and metal‐present environments, and may offer an interesting alternative target for developing treatments for AD that have not been considered thus far.
APP‐C31: An Intracellular Promoter of Both Metal‐Free and Metal‐Bound Amyloid‐β40 Aggregation and Toxicity in Alzheimer's Disease
Advanced Science
Nam, Eunju (Autor:in) / Lin, Yuxi (Autor:in) / Park, Jiyong (Autor:in) / Do, Hyunsu (Autor:in) / Han, Jiyeon (Autor:in) / Jeong, Bohyeon (Autor:in) / Park, Subin (Autor:in) / Lee, Da Yong (Autor:in) / Kim, Mingeun (Autor:in) / Han, Jinju (Autor:in)
Advanced Science ; 11
01.01.2024
Aufsatz (Zeitschrift)
Elektronische Ressource
Englisch
Dysregulation of Intracellular Calcium Signaling in Alzheimer's Disease
| British Library Online Contents | 2018
Microglial Lyzl4 Facilitates β‐Amyloid Clearance in Alzheimer's Disease
| Wiley | 2025
Microglial Lyzl4 Facilitates β‐Amyloid Clearance in Alzheimer's Disease
| Wiley | 2025
Immunological Approaches for Amyloid-beta Clearance Toward Treatment for Alzheimer's Disease
| British Library Online Contents | 2008